Literature DB >> 7841837

The pathogenesis of Campylobacter jejuni.

M R Wallis1.   

Abstract

Studies on the pathogenesis of Campylobacter jejuni show that for this organism to cause disease the susceptibility of the host and the relative virulence of the infecting strain are both important. Infection with C. jejuni results from the ingestion of contaminated food or water, and the infective dose can be as low as 800 organisms. To initiate infection the organism must penetrate the gastrointestinal mucus, which it does by using its high motility and spiral shape. The bacteria must then adhere to the gut enterocytes and once adhered can then induce diarrhoea by toxin release. C. jejuni releases several different toxins which vary from strain to strain, mainly enterotoxin and cytotoxins, and these correlate with the severity of the enteritis. During infection, levels of all immunoglobulin classes rise. Of these, IgA is the most important as it can cross the gut wall. IgA immobilises organisms, causing them to aggregate and activate complement, and also gives short-term immunity against the infecting strain of organism. The other immunoglobulin classes act on bacteria entering the blood stream, thus preventing bacteraemia. C. jejuni can also stimulate the cellular immune system, but this seems to play only a small role in preventing infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841837

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  10 in total

1.  Campylobacter jejuni induces maturation and cytokine production in human dendritic cells.

Authors:  Lan Hu; Mechelle D Bray; Manuel Osorio; Dennis J Kopecko
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

2.  Campylobacter jejuni-induced cytokine responses in avian cells.

Authors:  Chris K Smith; Pete Kaiser; Lisa Rothwell; Tom Humphrey; Paul A Barrow; Michael A Jones
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

3.  The in vitro susceptibility of Campylobacter spp. to the antibacterial effect of manuka honey.

Authors:  S M Lin; P C Molan; R T Cursons
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-26       Impact factor: 3.267

Review 4.  The chronic gastrointestinal consequences associated with campylobacter.

Authors:  Mark S Riddle; Ramiro L Gutierrez; Elena F Verdu; Chad K Porter
Journal:  Curr Gastroenterol Rep       Date:  2012-10

5.  Comparison of Campylobacter isolates from poultry and humans: association between in vitro virulence properties, biotypes, and pulsed-field gel electrophoresis clusters.

Authors:  Eric Nadeau; Serge Messier; Sylvain Quessy
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

6.  A peculiar case of Campylobacter jejuni attenuated aspartate chemosensory mutant, able to cause pathology and inflammation in avian and murine model animals.

Authors:  L E Hartley-Tassell; C J Day; E A Semchenko; G Tram; L I Calderon-Gomez; Z Klipic; A M Barry; A K Lam; M A McGuckin; V Korolik
Journal:  Sci Rep       Date:  2018-08-22       Impact factor: 4.379

Review 7.  DNA microarrays for the diagnosis of infectious diseases.

Authors:  E Donatin; M Drancourt
Journal:  Med Mal Infect       Date:  2012-10-09       Impact factor: 2.152

8.  Campylobacter jejuni motility integrates specialized cell shape, flagellar filament, and motor, to coordinate action of its opposed flagella.

Authors:  Eli J Cohen; Daisuke Nakane; Yoshiki Kabata; David R Hendrixson; Takayuki Nishizaka; Morgan Beeby
Journal:  PLoS Pathog       Date:  2020-07-02       Impact factor: 6.823

Review 9.  Could flies explain the elusive epidemiology of campylobacteriosis?

Authors:  Karl Ekdahl; Bengt Normann; Yvonne Andersson
Journal:  BMC Infect Dis       Date:  2005-03-07       Impact factor: 3.090

Review 10.  The Fate of Foodborne Pathogens in Manure Treated Soil.

Authors:  Zoe Black; Igori Balta; Lisa Black; Patrick J Naughton; James S G Dooley; Nicolae Corcionivoschi
Journal:  Front Microbiol       Date:  2021-12-10       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.